DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1

Research output: Contribution to journalShort surveypeer-review

Abstract

Breast Cancer Type 1 Susceptibility Protein (BRCA)-1 existing in several functionally distinct complexes, promotes DNA repair of DNA double-strand breaks (DSBs). A recent study by Tang and colleagues identifies the lysine methyltransferase Disruptor of Telomeric Silencing 1-Like (DOT1L) involved in modifying Receptor-Associated Protein 80 (RAP80) to promote BRCA1-A complex localization and repair functions at DNA breaks. This study illuminates a potential therapeutic target for cancer radiotherapy.

Original languageEnglish (US)
Pages (from-to)955-957
Number of pages3
JournalTrends in Pharmacological Sciences
Volume45
Issue number11
DOIs
StatePublished - Nov 2024

Keywords

  • BRCA1
  • DOT1L
  • RAP80
  • homologous recombination
  • radiotherapy

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Fingerprint

Dive into the research topics of 'DOT1L: orchestrating methylation-dependent radiotheRAPy responses via BRCA1'. Together they form a unique fingerprint.

Cite this